Isolated traces of the nitrosamine NDMA have been detected in individual diabetes preparations with the active substance metformin – investigations are ongoing worldwide.
Swissmedic Journal November 2019
Korrigendum / Klarstellung
Befristete Bewilligung zum Vertrieb in deutscher Aufmachung
FDHA has prompted to add substances to the Narcotics List to combat drug trafficking
Information concerning the new EU-Regulations as well as their implementation in Switzerland.
Communications regarding the safety of medicines
Product groups, services
Stay up to date
Our news subscription service provides on-going information via e-mail.
Reporting undesirable effects
Reporting incidents & FSCAs
The modifications following the ordinary revision of the TPA and its right of enforcement will enter into force on 1 January 2019
What is a medical device? How do medical devices come onto the market? How do you recognise a medical device? Based on examples, our videos answer these and a number of other questions.
Swissmedic monitors all safety measures and recalls for medical devices that are manufactured or marketed in Switzerland.
Swissmedic, Swiss Agency for Therapeutic Products
Swissmedic is the Swiss authority responsible for the authorisation and supervision of therapeutic products. Swissmedic's activities are based on the Law on Therapeutic Products.
For further information...